Evidence map›Paper›PMID 39050833›Full record

ArticleInfection and drug resistance2024

Colistin Resistance Mediated by

Samiratu Mahazu, Isaac Prah, Yusuke Ota, Takaya Hayashi, Masato Suzuki, Mitsunori Yoshida, Yoshihiko Hoshino, Yukihiro Akeda, Toshihiko Suzuki, Tomoko Ishino and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and drug resistance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Genomic and Virulence Characteristics ofPathogens (Basel, Switzerland) · 2025
    Article
  4. Pathogens (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Samiratu MahazuDepartment of Molecular Microbiology, Tokyo Medical and Dental University, Tokyo, Japan.
Isaac PrahDepartment of Molecular Microbiology, Tokyo Medical and Dental University, Tokyo, Japan.
Yusuke OtaDepartment of Molecular Microbiology, Tokyo Medical and Dental University, Tokyo, Japan.
Takaya HayashiDepartment of Molecular Virology, Tokyo Medical and Dental University, Tokyo, Japan.
Masato SuzukiAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Mitsunori YoshidaDepartment of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Yoshihiko HoshinoDepartment of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Yukihiro AkedaDepartment of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan.
Toshihiko SuzukiDepartment of Bacterial Pathogenesis, Tokyo Medical and Dental University, Tokyo, Japan.
Tomoko IshinoDepartment of Parasitology and Tropical Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Anthony Samuel AblordeyDepartment of Bacteriology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana.
Ryoichi SaitoDepartment of Molecular Microbiology, Tokyo Medical and Dental University, Tokyo, Japan.ORCID 0000-0003-3398-8572

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Colistin is classified by the World Health Organization (WHO) as a critically important and last-resort antibiotic for the treatment of infections caused by carbapenem-resistant bacteria. However, colistin resistance mediated by chromosomal mutations or plasmid-linked mobilized colistin resistance ( Methods: Thirteen Results: The minimum inhibitory concentration (MIC) of colistin for all except three isolates was >4 µg/mL. Nine new sequence types were identified and whole-genome analysis revealed that the isolates harbored genes ( Conclusion: The presence of

Indexed as

Aeromonas sppcolistinmcr-3-related genephosphoethanolamine transferaseswhole genome analysis

Identifiers

PMID39050833
PMCPMC11268572

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.